Ipilimumab vs Magnesium Carbonate
Ipilimumab vs Magnesium Carbonate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Magnesium Carbonate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Magnesium Carbonate β Small molecule.